Delivery Order SPE2DB20D3103-SPE2DB25FN8A4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,441.79 to AmerisourceBergen Drug Corp on October 22, 2025, for VEVYE 0.1% eye drop solution in 2 mL units. This is a firm fixed price delivery order with no set-aside designation, placed against AmerisourceBergen's larger pharmaceutical supply contract vehicle. The order is to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 23, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.80 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of VEVYE 0.1% eye drop solution in 2ML units. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete in...
- The Defense Logistics Agency awarded a $1,765.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ML) on July 21, 2025, with completion expected by July 22, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a $1,571.97 delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop (2ML) on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that...
- The Defense Logistics Agency awarded a delivery order valued at $7,727.57 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drops (2ML) on April 25, 2025, with an ultimate completion date of April 28, 2025. This competitively awarded, firm fixed-price delivery order was placed to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a routine pharmaceutical procurement under the company's existing contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $1,571.97 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop in 2ML units. This firm fixed price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The contract was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $9,438.39 to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2ML) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for VEVYE 0.1% eye drop in a 2ml formulation, with a ceiling value of $1,047.98. This competitive delivery order, issued under a firm fixed price arrangement, represents a continuation of pharmaceutical supply support through AmerisourceBergen's broader federal contracting relationship. The award carries no set-aside designation and is set for ultimate completion by August 6, 2025, with...
- The Defense Logistics Agency awarded a $1,105.62 firm fixed price delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drops (2ml) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $13,230.27 from the Defense Logistics Agency (DLA) on September 29, 2025, for VEVYE 0.1% eye drop solution in 2ML units. The contract employs firm fixed-price pricing with no set-aside designation, indicating it was competitively awarded. Performance will be executed at the awardee's Conshohocken location, with an ultimate completion date of September...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FN8A4Delivery Order
The Defense Logistics Agency awarded a $8,218.23 delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of VEVYE 0.1% eye drops in 2ml quantities. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 14, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle active through December 2026. As a major pharmaceutical distributor serving federal healthcare needs, AmerisourceBergen supplies an extensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The firm's federal contract performance demonstrates consistent capability to meet Defense Logistics Agency procurement requirements across diverse therapeutic categories and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 5/13/25 |